Abstract:Prostate cancer (PCa) is the second most frequently diagnosed solid tumor and the fifth leading cause of cancer mortality among men worldwide. The prostate specific antigen (PSA) test for PCa remains controversial. Therefore, the development of more effective non-invasive biomarkers for PCa is necessary. The present study evaluated the diagnostic value of microRNA (miR)-20b-5p in PCa. Tissue miR-20b-5p expression levels and their correlation with clinical parameters were assessed using The Cancer Genome Atlas (TCGA) datasets, and the diagnostic value of the miR-20b-5p expression levels in PCa tissues was assessed using receiver operating characteristic curve analysis. Reverse transcription-quantitative PCR (RT-qPCR) was used to assess the relative expression levels of miR-20b-5p in PCa tissues compared with benign prostate hyperplasia (BPH) tissues. In addition, miR-20b-5p expression levels in PCa cell lines and non-tumorigenic prostate epithelial cells were compared. In this study, exosomes were extracted from the prostatic fluid as a source of liquid biopsy for the detection of PCa. The prostatic fluid exosomal miR-20b-5p expression levels between patients with PCa and the biopsy-negative patients were compared, and the diagnostic efficiency of prostatic fluid exosomal miR-20b-5p expression levels in PCa was compared with PSA and with the European Randomized Study of Screening for Prostate Cancer (ERSPC) risk calculator. The mechanism by which miR-20b-5p may function in PCa was assessed using bioinformatic analysis and validation experiments. miR-20b-5p was expressed at a markedly higher level in PCa tissues compared with normal prostate tissues with high diagnostic efficiency (area under the curve: 0.826). The expression levels of miR-20b-5p were also significantly higher in PCa tissues compared with BPH tissues; similarly, miR-20b-5p was more highly expressed in PCa cells compared with non-tumorigenic prostate epithelial cells. Prostatic fluid exosomal miR-20b-5p expression levels in patients with PCa were significantly higher compared with confirmed to be biopsy-negative, and the diagnostic performance of miR-20b-5p was superior to PSA and ERSPC risk calculator. The results of RT-qPCR and western blotting following transfection of DU145 cells with miR-20b-5p mimics and inhibitor showed that miR-20b-5p reduced the expression of retinoblastoma-associated protein 1 (RB1). Therefore, RB1 may be a significant target gene for miR-20b-5p. In conclusion, the present study demonstrated that miR-20b-5p was upregulated in PCa at the tissue and cellular levels, as well as in prostatic fluid exosomes. Therefore, miR-20b-5p may be a promising early diagnostic biomarker for PCa and an important tool to guide the decision-making of prostate biopsy.

Expression and role of microRNA-381 in prostate cancer

Nonconserved Mir‐608 Suppresses Prostate Cancer Progression Through RAC2/PAK4/LIMK1 and BCL2L1/caspase‐3 Pathways by Targeting the 3′‐utrs of RAC2/BCL2L1 and the Coding Region of PAK4

MicroRNA-107 Inhibits Proliferation of Prostate Cancer Cells by Targeting Cyclin E1.

[miR-129 in the diagnosis, treatment and prediction of clinical prognosis of prostate cancer]

MicroRNA-335 Acts As a Candidate Tumor Suppressor in Prostate Cancer.

Mir-181a-5p Is Downregulated And Inhibits Proliferation And The Cell Cycle In Prostate Cancer

MicroRNA-181b Expression in Prostate Cancer Tissues and Its Influence on the Biological Behavior of the Prostate Cancer Cell Line PC-3.

Clinical competence of serum miR-372 expression in diagnosing prostate cancer

MicroRNA‐487a‐3p Functions As a New Tumor Suppressor in Prostate Cancer by Targeting CCND1

miRNA as diagnostic and prognostic biomarkers for patients with prostate cancer

MicroRNA‐19a Regulates Proliferation and Apoptosis of Castration‐resistant Prostate Cancer Cells by Targeting BTG1

Identification of Mirs-143 And-145 That is Associated with Bone Metastasis of Prostate Cancer and Involved in the Regulation of EMT

Expression of Microrna-129 in Prostate Cancer and Its Effect on Proliferation of PC-3 Cells

MicroRNA-302a Suppresses Tumor Cell Proliferation by Inhibiting AKT in Prostate Cancer.

Mir-20B-5p is a Novel Biomarker for Detecting Prostate Cancer.

Low Expression of Microrna-30C Promotes Prostate Cancer Cells Invasion Involved in Downregulation of KRAS Protein.

Mir-1231 is Downregulated in Prostate Cancer with Prognostic and Functional Implications

The potential of miR-153 as aggressive prostate cancer biomarker

Deregulation of Microrna-188-5p in Prostate Carcinoma and Effects on Proliferation and Metastasis of Prostate Carcinoma Cell Lines

MicroRNA-501-5p Targets PINX1 Gene to Regulate the Proliferation, Migration, and Invasion of Prostatic Carcinoma Cells

MiR-491-5p negatively regulates cell proliferation and motility by targeting PDGFRA in prostate cancer.